Cargando…

Peripheral Glycolysis in Neurodegenerative Diseases

Neurodegenerative diseases are a group of nervous system conditions characterised pathologically by the abnormal deposition of protein throughout the brain and spinal cord. One common pathophysiological change seen in all neurodegenerative disease is a change to the metabolic function of nervous sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Simon M., Burgess, Toby, Lee, James, Blackburn, Daniel J., Allen, Scott P., Mortiboys, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727792/ https://www.ncbi.nlm.nih.gov/pubmed/33255513 http://dx.doi.org/10.3390/ijms21238924

Ejemplares similares

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
por: Bell, Simon M., et al.
Publicado: (2021)

Clinical Trial Highlights: Modulators of Mitochondrial Function
por: Capriglia, Francesco, et al.
Publicado: (2023)

Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer’s Disease
por: Bell, Simon M., et al.
Publicado: (2020)

Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases
por: Süβ, Patrick, et al.
Publicado: (2021)

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
por: Török, Nóra, et al.
Publicado: (2020)

Curcumae Radix Decreases Neurodegenerative Markers through Glycolysis Decrease and TCA Cycle Activation
por: Jo, Seong-Lae, et al.
Publicado: (2022)

Genetic targeting of astrocytes to combat neurodegenerative disease
por: Kéry, Rachel, et al.
Publicado: (2019)

CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2009)

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
por: Piscopo, Paola, et al.
Publicado: (2021)

A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin
por: Younas, Neelam, et al.
Publicado: (2022)

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease
por: Bell, Simon M., et al.
Publicado: (2018)

Editorial: Peripheral immune system and neurodegenerative disease
por: Zhang, Ke, et al.
Publicado: (2022)

Editorial: Axonopathy in Neurodegenerative Disease
por: Burgess, Robert W., et al.
Publicado: (2018)

Methylxanthines and Neurodegenerative Diseases: An Update
por: Janitschke, Daniel, et al.
Publicado: (2021)

GSK-3 in Neurodegenerative Diseases
por: Lei, Peng, et al.
Publicado: (2011)

Tau imaging in neurodegenerative diseases
por: Dani, M., et al.
Publicado: (2015)

Association of gout with brain reserve and vulnerability to neurodegenerative disease
por: Topiwala, Anya, et al.
Publicado: (2023)

Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies
por: Stepien, Karolina M., et al.
Publicado: (2022)

Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review
por: Crook, Ashley, et al.
Publicado: (2021)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Mechanisms of protein toxicity in neurodegenerative diseases
por: Chung, Chang Geon, et al.
Publicado: (2018)

Proteotoxicity and Neurodegenerative Diseases
por: Ruz, Clara, et al.
Publicado: (2020)

Microglia in neurodegenerative diseases
por: Xu, Yu, et al.
Publicado: (2020)

Peroxiredoxins in Neurodegenerative Diseases
por: Szeliga, Monika
Publicado: (2020)

Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases
por: Martin, Lee J.
Publicado: (2010)

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
por: Zang, Xin, et al.
Publicado: (2022)

Editorial: Microglia and peripheral immune cells in aging and neurodegenerative diseases
por: Qiu, Yiguo, et al.
Publicado: (2023)

Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease
por: Jones, Simon P., et al.
Publicado: (2015)

Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
por: Onaolapo, Adejoke Y., et al.
Publicado: (2021)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

The Role of Microglia in the Development of Neurodegenerative Diseases
por: Lee, Jae-Won, et al.
Publicado: (2021)

Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil
por: Park, Joseph, et al.
Publicado: (2019)

Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
por: Malik, Bilal R., et al.
Publicado: (2019)

The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases
por: Abijo, Ayodeji, et al.
Publicado: (2023)

Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
por: Johnson, William M., et al.
Publicado: (2012)

The Role of Gene Editing in Neurodegenerative Diseases
por: Fan, Hueng-Chuen, et al.
Publicado: (2018)

Paraoxonase Role in Human Neurodegenerative Diseases
por: Reichert, Cadiele Oliana, et al.
Publicado: (2020)

Pentose Pathway Activation Is Superior to Increased Glycolysis for Therapeutic Angiogenesis in Peripheral Arterial Disease
por: Zaied, Abdelrahman A., et al.
Publicado: (2023)

Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases
por: Yang, Qiuyu, et al.
Publicado: (2020)

Ubiquitin, Autophagy and Neurodegenerative Diseases
por: Watanabe, Yoshihisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jf7i46l2f1f2f0r8gijtm0pe8u